New forms of insulin and insulin therapies for the treatment of type 2 diabetes-Reference-Cited by-同舟云学术

New forms of insulin and insulin therapies for the treatment of type 2 diabetes

Published:2015-08 Issue:8 Volume:3 Page:638-652
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Cahn Avivit,Miccoli Roberto,Dardano Angela,Del Prato Stefano

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference119 articles.

1. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future;Kahn;Lancet,2014

2. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes;Inzucchi;Diabetologia,2015

3. AACE comprehensive diabetes management algorithm 2013;Garber;Endocr Pract,2013

4. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada: methods;Booth;Can J Diabetes,2013

5. Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin Analogs and the Mode of Insulin Delivery: Recent Advances and Challenges;Current Pharmaceutical Biotechnology;2024-04-02

2. Solvent-free synthesis, biological evaluation and in silico studies of novel 2-amino-7-(bis(2-hydroxyethyl)amino)-4H-chromene-3-carbonitrile derivatives as potential a-amylase inhibitors;Journal of Molecular Structure;2024-04

3. Diabetic Cardiomyopathy—From Basics through Diagnosis to Treatment;Biomedicines;2024-03-29

4. Efficacy and safety of basal insulins in people with type 2 diabetes mellitus: a systematic review and network meta-analysis of randomized clinical trials;Frontiers in Endocrinology;2024-03-21

5. Management of type 2 diabetes in patients with compensated liver cirrhosis: Short of evidence, plenty of potential;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2024-01